Explore compound GLP3-R$280.00
Skip to content
RESEARCH, REFINED.
The details
Considered compounds. Documented standards.Explore our standard
RESEARCH, REFINED.Metabolic research
Cagrilintide
10 mg / $115.00
Cagrilintide is a long-acting, acylated analog of human amylin, engineered from the amylin scaffold with a fatty-diacid chain and anti-fibrillation substitutions that give it a multi-day half-life.
Available formats
1
Availability and final pricing are checked at checkout.
1 laboratory report availableFor laboratory research use only. Not for human consumption.
A closer look
The details
behind the compound.
Overview
Cagrilintide is a long-acting, acylated analog of human amylin, engineered from the amylin scaffold with a fatty-diacid chain and anti-fibrillation substitutions that give it a multi-day half-life. It functions as a dual amylin- and calcitonin-receptor agonist.
It is a distinctive reference within the metabolic category, studied for its role in satiety-signaling and receptor-pharmacology models.
- Molecular weight
- ≈4409 Da
- CAS number
- 1415456-99-3
Laboratory documentation
Check the product format and report identifiers before comparing results. Available reports do not establish the lot currently held in stock.
Vanguard LaboratoryAnalysis report · Lot CG26C010View reportResearch references
Kruse T, et al. Development of Cagrilintide, a long-acting amylin analogue. J Med Chem. 2021.
Lau DCW, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a phase 2 trial. Lancet. 2021.
Storage & handling
Store the lyophilized peptide below freezing (−80°C for the longest terms, −20°C otherwise). Reconstituted solution is aliquoted and held frozen to limit degradation.
